Journal of Histochemistry and Cytochemistry, Vol. 46, 1193-1198, October 1998, Copyright © 1998, The Histochemical Society, Inc.


BRIEF REPORT

Intracellular Retention of the Corticotrophin-releasing Hormone (CRH) Precursor Within COS-7 Cells

Marcelo J. Perone1,a, Simon Windeatt1,a, Ewan Morrisona, Andy Sheringa, Peter Tomaseca, Elizabeth Lintonb, Pedro R. Lowensteina, and Maria G. Castroa
a Molecular Medicine Unit, Department of Medicine, University of Manchester, Manchester, United Kingdom
b Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Maternity Hospital University of Oxford, Oxford, United Kingdom

Correspondence to: Maria G. Castro, Molecular Medicine Unit, Dept. of Medicine, U. of Manchester, Stopford Bldg., Rm. 1.302, Oxford Road, Manchester M139PT, UK. E-mail: mcastro@fs2.scg. man.ac.uk..


  Summary
Top
Summary
Introduction
Literature Cited

We investigated the intracellular localization of CRH in transiently transfected COS-7 cells expressing the full-length rat corticotropin-releasing hormone (CRH) precursor cDNA. CRH synthesized by transfected COS-7 cells is mainly stored intracellularly. In contrast, CHO-K1 cells expressing the same CRH precursor stored and released equal amounts of immunoreactive (IR)-CRH. Ultrastructural analysis revealed that CRH is stored in electron-dense aggregates in the RER of transiently transfected COS-7 cells and does not migrate into the Golgi apparatus. On the basis of the different intracellular localization, storage, and release of CRH in COS-7 and CHO-K1 cells, we hypothesize that the intracellular trafficking of CRH within the constitutive secretory pathway for protein secretion not only depends on its primary amino acid sequence but might also be influenced by intracellular conditions or factors. (J Histochem Cytochem 46:1193–1197, 1998)

Key Words: corticotropin-releasing, hormone, intracellular trafficking, constitutive secretory pathway, COS-7, CHO


  Introduction
Top
Summary
Introduction
Literature Cited

In the central nervous system, CRH is mainly expressed by and secreted from neurons of the hypothalamic paraventricular nucleus (Swanson et al. 1983 ). CRH in these cells is stored in large dense-core vesicles of the regulated secretory pathway for protein secretion and is released in response to extracellular stimuli. Basal, continuous, and unregulated release occurs via the constitutive secretory pathway. The CRH precursor is also synthesized at very high levels in the placenta, from which it is released via the constitutive secretory pathway (Perkins and Linton 1995 ). To examine the sorting and intracellular trafficking of the CRH precursor within the constitutive secretory pathway, we employed both transiently transfected COS-7 and stably transfected CHO-K1 cells expressing the full-length rat CRH precursor cDNA.

The establishment of the stably transfected CHO-K1 cell line expressing the rat CRH precursor has been previously described (Castro et al. 1995b ). COS-7 cells were transiently transfected using the plasmid pGWH1/rCRH. Both expression vectors encode exactly the same full-length rat CRH precursor cDNA under the control of exactly the same sequence of the major immediate early human cytomegalovirus (HCMV) promoter. The data shown in Table 1 and Table 2 compare the storage and secretion of CRH within stably transfected CHO-K1 cells and transiently transfected COS-7 cells expressing the CRH precursor. Transiently transfected COS-7 cells store more than 90% of total immunoreactive (IR)-CRH (Table 1). The transfection efficiency for COS-7 cells is 40–60% (results not shown). In contract, stably transfected CHO-K1 cells store and release approximately equal levels of IR-CRH (Table 2). It is possible that some IR-CRH could also be recovered in the medium due to cell lysis, which in both cell types at the time of assaying was 5%, as assessed by trypan blue exclusion. To investigate the trafficking of the CRH precursor within the secretory pathway, i.e., constitutive vs regulated pathway in transfected COS-7 and CHO-K1 cells, we stimulated the cells with 10-5 M forskolin, 10-3 M 8-Br-cAMP, and 51mM KCl. None of these secretagogues stimulated the release of IR-CRH (results not shown), thus indicating targeting of proCRH to the constitutive secretory pathway.


 
View this table:
[in this window]
[in a new window]
 
Table 1. IR-CRH stored and released in transiently transfected COS-7 cells (mean ± SEM)a


 
View this table:
[in this window]
[in a new window]
 
Table 2. IR-CRH stored and released in stably transfected CHO-K1 cells (mean ± SEM)a

To investigate the molecular forms of CRH synthesized by transiently transfected COS-7 cells, cell extracts were subjected to Western blotting as previously described (Castro et al. 1996 ) (data not shown). Three different anti-CRH antibodies (Matthew, 3B3, and Hannah) were employed. Two bands of approximately 21 and 19 kD were detected. The former band could account for the full-length CRH precursor and the latter for the CRH precursor devoid of its signal peptide. No other bands corresponding to smaller CRH peptides were observed, indicating that the CRH precursor did not undergo endoproteolytic processing within COS-7 cells.

To determine the time course of biosynthesis of CRH, COS-7 cells were metabolically labeled using [35S]-methionine/[35S]-cysteine at 48 hr post transfection. CRH was detected using immunoprecipitation followed by SDS-PAGE and autoradiography as described previously (Castro et al. 1995a ) (Figure 1). IR-CRH was detectable in cell extracts at 20 min after labeling and accumulated with time, but did not appear in culture supernatant until 2 hr after labeling. The major immunoreactive product observed in both cell extracts and culture medium was a band of 19 kD. The higher molecular weight band of 21 kD appeared in cell extracts after 4 hr labeling (Figure 1B, Lane 7). No other smaller molecular weight CRH-derived peptides, such as CRH(1–41), were detected. No bands corresponding to IR-CRH were seen in extracts or culture medium of nontransfected COS-7 cells metabolically labeled for 4 hr.



View larger version (48K):
[in this window]
[in a new window]
 
Figure 1. Metabolic labeling of transiently transfected COS-7 cells followed by SDS-PAGE and autoradiography. (A) Cell extract (Lane 1) and supernatant (Lane 2) from wild-type COS-7 cells labeled for 4 hr. Lanes 3, 5, and 7 show cell extracts and Lanes 4, 6, and 8 show supernatants from transfected COS-7 cells labeled for 10 min (Lanes 3 and 4), 20 min (Lanes 5 and 6), 40 min (Lanes 7 and 8). (B) Lanes 1 (cell extract) and 2 (supernatant) of wild-type COS-7 cells labeled for 4 hr not immunoprecipitated. Lanes 3, 5, and 7 show cell extracts and Lanes 4, 6, and 8 show supernatants from transfected COS-7 cells labeled for 1 hr (Lanes 3 and 4), 2 hr (Lanes 5 and 6) and 4 hr (Lanes 7 and 8). Molecular weight markers are indicated at left.

To elucidate the intracellular localization of IR-CRH within transiently transfected COS-7 cells, we performed immunoelectron microscopy. Figure 2A shows a transfected COS-7 cell next to an untransfected cell. The transfected cell contains the electron-dense structures within tubular membrane-bound compartments (Figure 2A, Figure 2B, and Figure 2D). The membranes are studded with ribosomes, identifying the organelle as the RER. Immunogold particles surrounding electron-dense aggregates confirm that they are immunoreactive for CRH (Figure 2C). Figure 2D shows the Golgi apparatus (G), which does not contain any electron-dense structures (arrows). Therefore, in transfected COS-7 cells, CRH is present within electron-dense aggregates in the RER. Transiently transfected COS-7 cells were also examined with confocal immunofluorescence microscopy (data not shown). IR-CRH did not co-localize with the Golgi marker TGN38 but it did co-localize with ER resident proteins (Louvard et al. 1982 ), confirming our EM data.



View larger version (151K):
[in this window]
[in a new window]
 
Figure 2. Electron microscopy of COS-7 cells transfected with the rat CRH precursor cDNA. (A,B,D) Cells processed in such a way as to preserve the integrity of membraneous structures. (A) A transfected cell (left) adjacent to an untransfected cell (right); small arrows indicate cell boundary. Note reticular structures (open arrow) containing electron-dense aggregates within the transfected cell. (A,D) The area occupied by the Golgi apparatus (G) is free of electron-dense aggregates. (B) Elongated (filled arrow) and transverse section (open arrow) of RER containing the electron-dense structures. (C) Electron-dense aggregates labeled with immunogold particles. Bars A = 500 nm; B–D = 90 nm.

Our EM data indicate that CRH condensation/aggregation occurs early within the secretory pathway of transfected COS-7 cells, i.e, the ER. This would also explain the relatively low levels of secreted IR-CRH detected in this study and the accumulation of intracellular IR-CRH within COS-7 cells. It has been previously shown that by starving and refeeding guinea pigs or injecting them with CoCl2 solution, the appearance of intracisternal granules (ICGs) within the RER of the exocrine pancreatic cells increases dramatically (Palade 1956 ; Geuze and Slot 1980 ; Tooze et al. 1989 ). Immunocytochemistry showed that these granules contain zymogens. These studies clearly demonstrate that condensation of regulated secretory proteins is not restricted to the trans-Golgi network (Tooze et al. 1989 ). The condensation–sorting hypothesis predicts that once proteins destined to be secreted through the regulated secretory pathway reach a critical concentration, they should come out of solution. Condensation of secretory proteins within the TGN appears to be a key event to sort proteins destined for regulated secretion (Burgess and Kelly 1987 ). Recent experimental evidence also suggests the involvement of a sorting receptor within the regulated secretory pathway (Cool et al. 1997 ). To the best of our knowledge, our results provide the first experimental evidence for the condensation of proneuropeptides within the RER of cells that do not possess a regulated pathway for protein secretion. Therefore, condensation per se is not an indication that proteins contained within the aggregates will be destined for regulated release, as has been proposed for ICGs and zymogen crystals in the exocrine guinea pig and rat pancreatic cells, respectively.

Our findings differ from previous studies on the release of secretory proteins from COS cells (Gething and Sambrook 1981 ; Lemay et al. 1989 ; Kato et al. 1990 ), which showed constant release via the constitutive secretory pathway. It is unlikely that saturation of the secretory apparatus through the overexpression of IR-CRH in COS-7 cells might lead to the formation of aggregates in the ER of transfected cells. Even at early time points post transfection, i.e., 12 hr or 24 hr (when the levels of stored CRH were less than 10% of those within stably transfected CHO-K1 cells) the release of CRH is still negligible (nil and 0.2 nM, respectively).

The molecular mechanisms that mediate the condensation/aggregation phenomenon encountered with the CRH precursor in COS-7 cells are at present unknown. Abnormal folding of the CRH precursor, as well as its possible association with cell proteins, might lead to aggregate formation within transfected COS-7 cells. Based on the differential behavior of CRH within both COS-7 and CHO-K1 transfected cells, we hypothesize that trafficking of the CRH precursor within the constitutive secretory pathway of COS-7 and CHO-K1 cells might be influenced by association with chaperones and/or the intracellular milieu.


  Footnotes

1 Should be considered first authors.


  Acknowledgments

Supported by project grants from the Biotechnology and Biological Sciences Research Council (Chemicals and Pharmaceuticals Directorate) and The Welcome Trust. We acknowledge the support from the Medical Research Council (MRC, UK), the Sir Halley Stewart Trust, the Cancer Research Campaign, the Royal Society, the Parkinson's Disease Society, REMEDI, and the Department of Medicine, University of Manchester. PRL is a Research Fellow of The Lister Institute of Preventive Medicine, UK.

We thank Dr B. Eipper for the TGN38 antibody and Dr E. Coudrier and Dr D. Louvard for the ER resident protein antibody.

Received for publication February 11, 1998; accepted May 26, 1998.


  Literature Cited
Top
Summary
Introduction
Literature Cited

Burgess TL, Kelly RB (1987) Constitutive and regulated secretion of proteins. Annu Rev Cell Biol 3:243-293

Castro MG, Lowenstein PR, Saphier PW, Linton EA, Lowry PJ (1990) The use of inclusion-bodies, isolated from Escherichia-coli expressing corticotropin-releasing hormone precursor, to raise specific antibodies against the neuropeptide moiety. J Mol Endocrinol 5:221-230[Abstract]

Castro MG, Morrison E, Perone MJ, Brown OA, Murray CA, Ahmed I, Perkins AV, Europe–Finner G, Lowenstein PR, Linton EA (1996) Corticotropin-releasing hormone-receptor type-1. Generation and characterization of polyclonal antipeptide antibodies and their localization in pituitary-cells and cortical-neurons in vitro. J Neuroendocrinol 8:521-531[Medline]

Castro MG, Morrison E, Tomasec P, Linton EA, Lowenstein PR (1995a) Colocalization of autoimmune antibodies specific for double-stranded DNA with procorticotrophin-releasing hormone within the nucleus of stably transfected CHO-K1 cells. Cell Tissue Res 282:367-376[Medline]

Castro MG, Rowe J, Morrison E, Tomasec P, Murray CA, Shering AF, Lowenstein PR (1995b) Calcium–phosphate, DEAE–dextran coprecipitation, and electroporation to transfer genes into neuronal and glial cell lines. In Lowenstein PR, Enquist LW, eds. Protocols for Gene Transfer in Neuroscience. Chichester, Wiley, 9-23

Cool DR, Normant E, Shen FS, Chen HC, Pannel L, Zhang Y, Loh YP (1997) Carboxypeptidase E is a regulated secretory pathway sorting receptor: genetic obliteration leads to endocrine disorders in Cpefat mice. Cell 88:73-83[Medline]

Gething MJ, Sambrook J (1981) Cell-surface expression of influenza hemagglutinin from a cloned DNA copy of the RNA gene. Nature 293:620-625[Medline]

Geuze HJ, Slot W (1980) Disproportional immunostaining patterns of two secretory proteins in guinea pig and rat exocrine pancreatic cells: immuno-ferritin and fluorescence study. Eur J Cell Biol 21:93-100[Medline]

Kato Y, Shimokawa N, Kato T, Hiria T, Yoshihama K, Kawai H, Hattori M, Ezashi T, Shimogori Y, Wakabayashi K (1990) Porcine growth-hormone molecular cloning of cDNA and expression in bacterial and mammalian cells. Biochim Biophys Acta 1048:290-293[Medline]

Lemay G, Waksman G, Roques BP, Crine P, Boileau G (1989) Fusion of a cleavable signal peptide to the ectodomain of a neutral endopeptidase (EC 3.4.24.11) results in the secretion of an active enzyme in COS-1 cells. J Biol Chem 264:15620-15623[Abstract/Free Full Text]

Louvard D, Reggio H, Warren G (1982) Antibodies to the Golgi-complex and the rough endoplasmic-reticulum. J Cell Biol 92:92-107[Abstract]

Palade GE (1956) Intracisternal granules in the exocrine cells of the pancreas. J Biophys Biochem Cytol 2:417-422[Abstract/Free Full Text]

Perkins AV, Linton EA (1995) Placental corticotropin-releasing hormone. There by accident or design. J Endocrinol 147:377-381[Medline]

Swanson LW, Sawchenko PE, Rivier J, Vale WW (1983) Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain. An histochemical study. Neuroendocrinology 36:165-186[Medline]

Tooze J, Kern HF, Fuller SD, Howell KE (1989) Condensation sorting events in the rough endoplasmic reticulum of exocrine pancreatic-cells. J Cell Biol 109:35-50[Abstract]